Enterococcus hirae is a Gram-positive coccus that was isolated from about 5-10 days old young duck fecal stool.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Product Information | |
---|---|
Product Overview | Enterococcus hirae is a Gram-positive coccus that was isolated from about 5-10 days old young duck fecal stool. |
Target | Enterococcus |
Genus | Enterococcus |
Strain Designation | 2-3 |
Application | Study and research |
Type Strain | No |
Culture Medium | GAM |
Culture Conditions | 37°C; Facultative anaerobic |
Source | About 5-10 days old young duck fecal stool |
Risk Group | 1 |
Product Format | Freeze-dried |
Packaging | Ampoule tube |
Storage | -80°C |
Shelf Life | 6 years |
Target Introduction | |
---|---|
Introduction | Enterococcus are lactic acid bacteria; LAB comprising both pathogenic and commensal microorganisms ubiquitous in environment even as gut symbionts. They are extensively studied as potential candidate probiotics. Several number of Enterococcus strains have been reported to produce antimicrobial compounds including bacteriocins. Bacteriocin production have be applied to preservation of a wide range of food products and is now being considered as a probiotic trait. Besides, bacteriocins are considered as promising alternative to fight emerging antimicrobial resistance. Enterococcus probiotics can be used in treatment and/or prevention of certain human and animal diseases such as alleviation of irritable bowel syndrome symptoms and antibiotic-induced diarrhea and prevention of different functional and chronic intestinal diseases. Moreover, some Enterococcus exhibit anticarcinogenic, hypocholesterolemic, as well as immune regulation effects. |
Alternative Names | Enterococcus hirae; 2-3 |
Enterococcus hirae; 2-3 can be incorporated into probiotic formulations after assessing its safety, viability, and functional properties. Techniques such as freeze-drying and microencapsulation help maintain its stability and efficacy in various delivery forms, including capsules and powders.
The immune-modulating effects of Enterococcus hirae; 2-3 can be assessed by co-culturing with human immune cells and measuring cytokine production using ELISA or flow cytometry. Gene expression analysis of immune-related genes can provide further insights into its immunomodulatory potential.
Functional genomics of Enterococcus hirae; 2-3 can be studied using tools such as CRISPR-Cas9 for gene editing, RNA sequencing for transcriptome analysis, and plasmid vectors for gene overexpression or knockout studies. These tools facilitate a deeper understanding of its probiotic properties.
The antimicrobial activity of Enterococcus hirae; 2-3 is evaluated using agar well diffusion, disk diffusion, or broth microdilution assays. These methods help quantify its inhibitory effects on pathogenic bacteria and assess its potential as a probiotic with antimicrobial properties.
Quality control measures include verifying strain identity through molecular techniques, ensuring absence of virulence factors, maintaining aseptic conditions, and performing regular viability and stability tests. These practices ensure reliable and reproducible research outcomes.
Click the button below to contact us or submit your feedback about this product.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2024 Creative Biolabs. All Rights Reserved.